(59 days)
No
The description focuses on the sensor's physical characteristics, compatibility, and basic data storage ("memory chip carrying information"). There is no mention of AI, ML, or advanced data processing beyond "Advanced Signal Evaluation," which is a common term in pulse oximetry and doesn't necessarily imply AI/ML.
No
This device is a sensor used for monitoring oxygen saturation and pulse rate, not for providing therapy.
No
This device is an oxygen sensor that monitors arterial oxygen saturation and pulse rate; it provides data but does not diagnose a condition.
No
The device description explicitly states that the device is a "sensor" and contains a "memory chip," indicating it is a hardware component designed to be physically attached to a patient for monitoring.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The description clearly states that the Nellcor OxiMax SoftCare oxygen sensors are "noninvasive" and used for "continuous noninvasive arterial oxygen saturation and pulse rate monitoring." This means they are applied externally to the patient's body and do not involve analyzing samples taken from the body.
- Intended Use: The intended use is to monitor physiological parameters (oxygen saturation and pulse rate) directly from the patient, not to analyze biological samples.
Therefore, this device falls under the category of a non-invasive physiological monitoring device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
The Nellcor OxiMax SoftCare adult oxygen sensor, model SC-A, is indicated for single patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for adults weighing more than 40 kg.
The Nellcor OxiMax SoftCare preterm infant oxygen sensor, model SC-PR, is indicated for single-patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for neonates weighing less than 1.5 kg.
The Nellcor OxiMax SoftCare neonatal oxygen sensor, model SC-NEO, is indicated for single-patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for neonates weighing 1.5 kg to 5 kg.
The Nellcor OxiMax SoftCare neonatal oxygen sensor, model SC-N, is indicated for single-patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for neonates weighing less than 3 kg.
The OxiMax SoftCare Sensors are indicated for single-patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required.
Product codes
DQA
Device Description
The OxiMax SoftCare sensors are sterile, latex-free, single patient use, non-adhesive The Oxiviax SoftCare Schools are Sterne, Intell 1900, estem as a means of attachment. Sensors. These sensors have a noon and soft and soft as a more is eliminated.
These sensors contain a memory chip carrying information about the sensor which the oximeter needs for correct operation, including in-sensor data, Advanced Signal Evaluation, lot code and data set revision, and sensor model. The OxiMax SoftCare sensors are compatible with OxiMAX monitors.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Adults weighing more than 40 kg.
Neonates weighing less than 1.5 kg.
Neonates weighing 1.5 kg to 5 kg.
Neonates weighing less than 3 kg.
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Human and bench tests were performed to support the determination of substantial equivalence. Human oxygenation evaluations were conducted to confirm conformance to accuracy and precision specifications.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2700 Oximeter.
(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes forming its body and head. The eagle is facing to the right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
Public Health Service
MAY 2 3 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Ms. Gina To Senior Regulatory Affairs Project Manager Nellcor Puritan Bennett Incorporated 4280 Hacienda Drive Pleasanton, California 94588
Re: K030930
Trade/Device Name: OxiMax SoftCare Sensor Models SC-A, SC-PR, SC-NEO, SC-N Regulation Number: 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: DQA Dated: March 24, 2003 Received: March 25, 2003
Dear Ms. To:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Page 2 - Ms. To
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a " promatics nothleated." The 127 I midnig of backanial of your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Susan Ruasr
Susan Runner, DDS, MA Interim Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Page of
510(k) Number (if known): KO30 930
Nellcor® OxiMax™ SoftCare™ Sensors Device Name:
Indications For Use:
The Nellcor OxiMax SoftCare adult oxygen sensor, model SC-A, is indicated for single patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for adults weighing more than 40 kg.
The Nellcor OxiMax SoftCare preterm infant oxygen sensor, model SC-PR, is indicated for single-patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for neonates weighing less than 1.5 kg.
The Nellcor OxiMax SoftCare neonatal oxygen sensor, model SC-NEO, is indicated for single-patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for neonates weighing 1.5 kg to 5 kg.
The Nellcor OxiMax SoftCare neonatal oxygen sensor, model SC-N, is indicated for single-patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for neonates weighing less than 3 kg.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
G.H. Watson
eneral Hospital.
510(k) Number: K030930
Prescription Use V
OR
Over-The-Counter Use
Optional Format (1-2-96)
3
4280 Hacienda Drive Pleasanton, CA 94588
Tele: 925 463-4000 Fax: 925 463-4020
52
12
tuco
Healthcare
Nellcor
510(k) Summary
Submitted by:
Nellcor Puritan Bennett, Inc. 4280 Hacienda Drive Pleasanton, CA 94588
Company Contact:
Gina To Senior Regulatory Affairs Project Manager (925) 463-4427 (925) 463-4020 - FAX
March 24, 2003 Date Summary Prepared:
Trade Name:
Common/Usual Name:
Oxygen Sensor
Oximeter (DQA) per 21 CFR §870.2700 Classification Name:
Nellcor Puritan Bennett, Inc., OxiMax Pulse Oximetry Legally Marketed System with N-595 Pulse Oximeter and OxiMax Sensors, (Unmodified) Device: K012891
OxiMax™ SoftCare™ Sensors
DEVICE DESCRIPTION
The OxiMax SoftCare sensors are sterile, latex-free, single patient use, non-adhesive The Oxiviax SoftCare Schools are Sterne, Intell 1900, estem as a means of attachment. Sensors. These sensors have a noon and soft and soft as a more is eliminated.
These sensors contain a memory chip carrying information about the sensor which the oximeter needs for correct operation, including in-sensor data, Advanced Signal Evaluation, lot code and data set revision, and sensor model. The OxiMax SoftCare sensors are compatible with OxiMAX monitors.
INTENDED USE
The OxiMax SoftCare Sensors are indicated for single-patient use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required.
4
SUMMARY OF TECHNOLOGICAL CHARACTERISTICS OF THE DEVICE COMPARED TO THE PREDICATE DEVICE
The OxiMax SoftCare Sensors have the same technological characteristics as the OxiMax MAX-N. The differences relate to patient contact surface, attachment means, electro-optical specifications, and labeling. The dimensions of the MAX-N have been modified to result in four distinct SoftCare sensors, to provide different sized sensors and graphics for various patient weight ranges within the adult and neonatal populations.
TESTS PERFORMED TO SUPPORT DETERMINATION OF SUBSTANTIAL EQUIVALENCE
Human and bench tests were performed to support the determination of substantial equivalence. Human oxygenation evaluations were conducted to confirm conformance to accuracy and precision specifications.
CONCLUSIONS
The technological characteristics of the OxiMax SoftCare Sensors and the results of testing do not raise new questions of safety or effectiveness when compared to the legally marketed predicate device.
25
13